Cooperative Study of Factor VIII Inhibitors

NCT00000582 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Blood Coagulation Disorders
Hematologic Diseases
Hemophilia A
Hemorrhagic Disorders

Interventions

DRUG: factor ix

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)